Representative Transactions

SC&H Capital advises Unjury® in Sale to Blueroot Health™, a portfolio company of North Castle Partners.

Thanks to SC&H Capital for your great work for Unjury®/ProSynthesis Laboratories, Inc. My headline comment is about the bottom line; you created tremendous value managing our process and negotiating with the buyer of our business. I was not just impressed; I felt lucky to have you on our side, not their side. In any deal, there are certain points when value can be added or lost. You and your team nailed the two crucial opportunities: valuation, and negotiation. A great win! Thank you!

Jerome Krachenfels

President Unjury®

Unjury® is a branded medical food company specializing in protein and vitamin supplements. The Company provides nutritional support in powders, bars, ready-to-drink shakes, and vitamins focused on bariatric patients, cancer patients, diabetic patients, and pregnant or nursing women. The Company’s products are recommended at America’s top-rated hospitals and have a worldwide following.

Founder and owner, Jerome Krachenfels, built a brand with a strong track record, reputation, and following among hospitals, practitioners, and consumers. As a recognized leader in the medical food space, Jerome was frequently approached by potential buyers and investors inquiring about his interest in being acquired.

Jerome approached SC&H Capital to help prepare Unjury® to engage with a select handful of highly strategic buyers. SC&H helped Unjury® prepare its financial and accounting records, and selected the potential buyers based on Unjury’s® value proposition and our knowledge of buyer priorities. SC&H used our insight into market trends to negotiate a successful transaction with Blueroot Health™, a portfolio company of North Castle Partners.

Read Full Press Release